American Heart Association, Nov. 16-18
                    
The American Heart Association Scientific Sessions 2019  The annual meeting of the American Heart Association was held from Nov. 16 to 18 in...                
            Cardiovascular Disease Rates Dropping in American Indians
                    Fewer men are dying from heart disease-related events, but women seeing less improvement                
            Vigorous Activity Weekly May Improve Outcomes in Stable CAD
                    Vigorous activity once, twice weekly may lower cardiac risk in stable coronary artery disease                
            Rheumatoid Arthritis Linked to Comorbidities Before, After Diagnosis
                    Increased odds of inflammatory bowel disease, type 1 diabetes, VTE seen before RA diagnosis versus controls                
            Statin Use Not Linked to Rate of Cognitive Decline in Seniors
                    Rate of decline in memory, global cognition similar for elderly statin users, never users over six-year period                
            AHA: Lower-Target LDL Level Beneficial After Stroke, TIA
                    Subsequent risk for CV events lower among patients with ischemic stroke, TIA, evidence of atherosclerosis                
            AHA: Neurohormonal Blockade Beneficial for Patients With LVAD
                    At four years, survival better among patients with LVADs receiving any NHB medication at six months                
            VA, DoD Update Guideline for Rehabilitation After Stroke
                    Systematic review addresses effectiveness of pharmacological, nonpharmacological interventions                
            CDC: ~20 Percent of U.S. Adults Currently Use Tobacco Products
                    Prevalence of use higher for men, adults aged ≤65 years, uninsured, those with disability or limitation                
            HbA1c Variability Linked to Cardiovascular Disease Risk
                    Risks increased for all-cause mortality, cardiovascular events, microvascular complications                
            
                
		















